FDA Moves Forward On Study Of Drug Ad Offers
The U.S. Food and Drug Administration said Wednesday it had received the go-ahead to research the effects of promotional offers in direct-to-consumer prescription drug print advertising, a study the agency first...To view the full article, register now.
Already a subscriber? Click here to view full article